Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.
Neurooncol Adv. 2023 Jul 20;5(1):vdad090. doi: 10.1093/noajnl/vdad090. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37547266
Free PMC article.
Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey.
Kebir S, Lazaridis L, Wick W, Platten M, Tabatabai G, Combs SE, Schmidt T, Agkatsev S, Blau T, Mäurer I, Kahlert U, Sagerer A, Berberich A, Heider S, Müther M, Bodensohn R, Behling F.
Kebir S, et al. Among authors: agkatsev s.
Neuro Oncol. 2022 Sep 1;24(9):1609-1611. doi: 10.1093/neuonc/noac114.
Neuro Oncol. 2022.
PMID: 35639965
Free PMC article.
No abstract available.
Item in Clipboard
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastoma.
Lazaridis L, Bumes E, Cäcilia Spille D, Schulz T, Heider S, Agkatsev S, Schmidt T, Blau T, Oster C, Feldheim J, Stummer W, Kessler AF, Seidel C, Grauer O, Hau P, Sure U, Keyvani K, Herrlinger U, Kleinschnitz C, Stuschke M, Herrmann K, Deuschl C, Breuer S, Hattingen E, Scheffler B, Kebir S, Glas M.
Lazaridis L, et al. Among authors: agkatsev s.
Neurooncol Adv. 2022 Aug 24;4(1):vdac137. doi: 10.1093/noajnl/vdac137. eCollection 2022 Jan-Dec.
Neurooncol Adv. 2022.
PMID: 36284931
Free PMC article.
Item in Clipboard
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.
Oster C, Schmidt T, Agkatsev S, Lazaridis L, Kleinschnitz C, Sure U, Scheffler B, Kebir S, Glas M.
Oster C, et al. Among authors: agkatsev s.
Neurooncol Adv. 2023 Sep 4;5(1):vdad105. doi: 10.1093/noajnl/vdad105. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37811538
Free PMC article.
Review.
Item in Clipboard
A Genomic DNA Reporter Screen Identifies Squalene Synthase Inhibitors That Act Cooperatively with Statins to Upregulate the Low-Density Lipoprotein Receptor.
Kerr AG, Tam LCS, Hale AB, Cioroch M, Douglas G, Agkatsev S, Hibbitt O, Mason J, Holt-Martyn J, Bataille CJR, Wynne GM, Channon KM, Russell AJ, Wade-Martins R.
Kerr AG, et al. Among authors: agkatsev s.
J Pharmacol Exp Ther. 2017 Jun;361(3):417-428. doi: 10.1124/jpet.116.239574. Epub 2017 Mar 30.
J Pharmacol Exp Ther. 2017.
PMID: 28360334
Free PMC article.
Item in Clipboard
RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo.
Hibbitt O, Agkatsev S, Owen C, Cioroch M, Seymour L, Channon K, Wade-Martins R.
Hibbitt O, et al. Among authors: agkatsev s.
Gene Ther. 2012 Apr;19(4):463-7. doi: 10.1038/gt.2011.103. Epub 2011 Jul 28.
Gene Ther. 2012.
PMID: 21796214
Item in Clipboard
Cite
Cite